Showing results (131-140 of 1,374) with videos related to
Sort By:
Pageof 138
Neuroscience Letters|February 15, 2001
Decreased brain histamine-releasing factor protein in patients with Down syndrome and Alzheimer's diseaseS H Kim, N Cairns, M Fountoulakisc, et al.Dementia and Geriatric Cognitive Disorders|March 13, 2001
Synaptosomal proteins, beta-soluble N-ethylmaleimide-sensitive factor attachment protein (beta-SNAP), gamma-SNAP and synaptotagmin I in brain of patients with Down syndrome and Alzheimer's diseaseB C Yoo, N Cairns, M Fountoulakis, et al.Padiatrie Und Padologie|January 1, 1988
The determination of urinary 3-trans-hydroxyproline (3 OHP). I. Normal values in school children and adultsM T Weiss, M Weninger, J Häusler, et al.Journal of Neural Transmission. Supplementum|January 5, 2002
Decreased protein levels of complex I 30-kDa subunit in fetal Down syndrome brainsS H Kim, M Fountoulakis, M Dierssen, et al.Journal of Neural Transmission. Supplementum|January 5, 2002
Expression patterns of chaperone proteins in cerebral cortex of the fetus with Down syndrome: dysregulation of T-complex protein 1B C Yoo, M Fountoulakis, M Dierssen, et al.Journal of Neural Transmission. Supplementum|January 5, 2002
Decreased levels of ARPP-19 and PKA in brains of Down syndrome and Alzheimer's diseaseS H Kim, A C Nairn, N Cairns, et al.Renal Physiology|January 1, 1980
Proteolytic degradation of the glomerular basement membrane and immunochemical characterization of split productsG Lubec, O Förster, H Coradello, et al.Zeitschrift Fur Hautkrankheiten|May 1, 1983
[Manifold reflection infrared spectroscopy of the hair of mice with an experimental amino acid metabolism disease (L-acetidin-2-carboxylic acid incorporation instead of proline). A model for the use of infrared spectroscopy as a screening method for metabolic diseases]G Lubec, G Nauer, A Pollak, et al.Journal of Neural Transmission. Supplementum|January 5, 2002
Expression of apoptosis related proteins: RAIDD, ZIP kinase, Bim/BOD, p21, Bax, Bcl-2 and NF-kappaB in brains of patients with Down syndromeE Engidawork, T Gulesserian, R Seidl, et al.Biochemical and Biophysical Research Communications|January 27, 1999
Evidence against the current hypothesis of "gene dosage effects" of trisomy 21: ets-2, encoded on chromosome 21" is not overexpressed in hearts of patients with Down SyndromeS Greber-Platzer, D Schatzmann-Turhani, G Wollenek, et al.Pageof 138